The SOD1 enzymatic activity found in the patient is the lowest activity ever reported in an ALS patient [5–7] and may have impact on therapeutic approaches with antisense nucleotides lowering SOD1 activity. Here, SOD1 is linked to amyotrophic lateral sclerosis.